Found 5 matching trials
Autologous Polyclonal Tregs for Lupus
PHASE1The primary purpose of this Phase 1 study is to evaluate the safety, tolera...
Location
University of California, San Francisco
T1DM Immunotherapy Using CD4+CD127lo/-CD25+ Polyclonal Tregs
PHASE1The investigational therapy under study in this trial, regulatory T cells (...
Location
University of California, San Francisco Medical Center
Immunotherapy with Autologous Tregs in T1DM
PHASE1Type 1 diabetes (T1D) is an autoimmune disease characterized by a progressi...
Location
The Department of Endocrinology, The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
T1DM Immunotherapy Using Polyclonal Tregs + IL-2
PHASE1The purpose of this study is to assess the safety of Tregs + IL-2 and survi...
Location
University of California, San Francisco Medical Center
Treg Immunotherapy in Crohn's Disease
PHASE1Crohn's Disease (CD) is a condition that causes inflammation of the digesti...
Location
Guy's Hospital - Guy's and St Thomas' NHS Foundation Trust